[SY1-4]Brainshuttle™ AD - a Phase Ib/IIa study of trontinemab in people with Alzheimer’s disease
○Luka Kulic1, Fabien Alcaraz1, Carsten Hofmann1, Denise Sickert1, Maddalena Marchesi1, Jakub Wojtowicz1, Gregory Klein1, Ruth Croney1, David Agnew1, João Abrantes1, Silke Ahlers2, Paul Delmar1, Iris Wiesel1(1.F. Hoffmann-La Roche Ltd., 2.Excelya Germany GmbH)
Password required to view
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.
Password is required to view the abstract. Please enter a password to authenticate.